SightfileU.S. market data from official filings

Companies › NERV

Minerva Neurosciences Inc (NERV)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001598646 · EDGAR filings · Updated 2026-07-08

Minerva Neurosciences Inc (NERV) has reported institutional ownership of 88.5%, with 44 institutional managers holding positions valued at $230.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
88.5%
Institutional managers
44
Reported 13F value
$230.8M
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Minerva Neurosciences Inc has 44 institutional holders and institutional ownership of 88.5%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-10-11 (recurring since 2022-01-18) — source filing. The authoritative details are those stated in the filing itself.

Related companies

RXSIGHT INC (RXST) · STRATA CRITICAL MEDICAL INC (SRTA) · OVID THERAPEUTICS INC (OVID) · OPKO HEALTH INC (OPK) · VIEMED HEALTHCARE INC (VMD) · CABALETTA BIO INC (CABA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-08.